158 related articles for article (PubMed ID: 18536753)
1. Anti-inflammatory actions of aprotinin provide dose-dependent cardioprotection from reperfusion injury.
Carter J; Buerke U; Rössner E; Russ M; Schubert S; Schmidt H; Ebelt H; Pruefer D; Schlitt A; Werdan K; Buerke M
Br J Pharmacol; 2008 Sep; 155(1):93-102. PubMed ID: 18536753
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotective effects of the serine protease inhibitor aprotinin after regional ischemia and reperfusion on the beating heart.
Pruefer D; Buerke U; Khalil M; Dahm M; Darius H; Oelert H; Buerke M
J Thorac Cardiovasc Surg; 2002 Nov; 124(5):942-9. PubMed ID: 12407377
[TBL] [Abstract][Full Text] [Related]
3. Selectin-targeting glycosaminoglycan-peptide conjugate limits neutrophil-mediated cardiac reperfusion injury.
Dehghani T; Thai PN; Sodhi H; Ren L; Sirish P; Nader CE; Timofeyev V; Overton JL; Li X; Lam KS; Chiamvimonvat N; Panitch A
Cardiovasc Res; 2022 Jan; 118(1):267-281. PubMed ID: 33125066
[TBL] [Abstract][Full Text] [Related]
4. Oxytocin ameliorates the immediate myocardial injury in rat heart transplant through downregulation of neutrophil-dependent myocardial apoptosis.
Al-Amran F; Shahkolahi M
Transplant Proc; 2013; 45(6):2506-12. PubMed ID: 23953571
[TBL] [Abstract][Full Text] [Related]
5. Reduction in myocardial ischemic/reperfusion injury and neutrophil accumulation after therapeutic administration of streptokinase.
Smith EF; Nichols AJ; Sellers TS; O'Brien SR; Griswold DE; Egan JW; Hillegass LM; Vasko JA; Slivjak MJ; Davis PA
J Cardiovasc Pharmacol; 1991 Nov; 18(5):729-38. PubMed ID: 1723770
[TBL] [Abstract][Full Text] [Related]
6. Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition.
Schwertz H; Carter JM; Russ M; Schubert S; Schlitt A; Buerke U; Schmidt M; Hillen H; Werdan K; Buerke M
J Cardiovasc Pharmacol; 2008 Aug; 52(2):151-60. PubMed ID: 18670364
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotection by a novel recombinant serine protease inhibitor in myocardial ischemia and reperfusion injury.
Murohara T; Guo JP; Lefer AM
J Pharmacol Exp Ther; 1995 Sep; 274(3):1246-53. PubMed ID: 7562495
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo.
Oerlemans MI; Liu J; Arslan F; den Ouden K; van Middelaar BJ; Doevendans PA; Sluijter JP
Basic Res Cardiol; 2012 Jul; 107(4):270. PubMed ID: 22553001
[TBL] [Abstract][Full Text] [Related]
9. Plasmin inhibitors prevent leukocyte accumulation and remodeling events in the postischemic microvasculature.
Reichel CA; Lerchenberger M; Uhl B; Rehberg M; Berberich N; Zahler S; Wymann MP; Krombach F
PLoS One; 2011 Feb; 6(2):e17229. PubMed ID: 21364954
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotection by liposome-conjugated sialyl Lewisx-oligosaccharide in myocardial ischaemia and reperfusion injury.
Murohara T; Margiotta J; Phillips LM; Paulson JC; DeFrees S; Zalipsky S; Guo LS; Lefer AM
Cardiovasc Res; 1995 Dec; 30(6):965-74. PubMed ID: 8746213
[TBL] [Abstract][Full Text] [Related]
11. Sialyl Lewisx-containing oligosaccharide attenuates myocardial reperfusion injury in cats.
Buerke M; Weyrich AS; Zheng Z; Gaeta FC; Forrest MJ; Lefer AM
J Clin Invest; 1994 Mar; 93(3):1140-8. PubMed ID: 7907602
[TBL] [Abstract][Full Text] [Related]
12. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
Mueller M; Herzog C; Larmann J; Schmitz M; Hilfiker-Kleiner D; Gessner JE; Theilmeier G
Immunobiology; 2013 Sep; 218(9):1131-8. PubMed ID: 23642836
[TBL] [Abstract][Full Text] [Related]
13. Aprotinin and preservation of myocardial function after ischemia-reperfusion injury.
Bull DA; Maurer J
Ann Thorac Surg; 2003 Feb; 75(2):S735-9. PubMed ID: 12607720
[TBL] [Abstract][Full Text] [Related]
14. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
[TBL] [Abstract][Full Text] [Related]
15. Peroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats.
Nossuli TO; Hayward R; Scalia R; Lefer AM
Circulation; 1997 Oct; 96(7):2317-24. PubMed ID: 9337206
[TBL] [Abstract][Full Text] [Related]
16. Tetrandrine ameliorates ischaemia-reperfusion injury of rat myocardium through inhibition of neutrophil priming and activation.
Shen YC; Chen CF; Sung YJ
Br J Pharmacol; 1999 Dec; 128(7):1593-601. PubMed ID: 10602341
[TBL] [Abstract][Full Text] [Related]
17. Does aprotinin modify the effects of ischaemia-reperfusion on the myocardial performance of a blood perfused isolated rabbit heart?
Sirieix D; Clinquart F; Delayance S; Massonnet-Castel S; Paris M; Baron JF
Eur J Anaesthesiol; 1999 Oct; 16(10):712-8. PubMed ID: 10583356
[TBL] [Abstract][Full Text] [Related]
18. 2-methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction.
Hwa JS; Jin YC; Lee YS; Ko YS; Kim YM; Shi LY; Kim HJ; Lee JH; Ngoc TM; Bae KH; Kim YS; Chang KC
J Ethnopharmacol; 2012 Jan; 139(2):605-15. PubMed ID: 22179023
[TBL] [Abstract][Full Text] [Related]
19. Administration of adenosine during reperfusion reduces injury of vascular endothelium and death of myocytes.
Zhao ZQ; Nakamura M; Wang NP; Wilcox JN; Shearer S; Guyton RA; Vinten-Johansen J
Coron Artery Dis; 1999 Dec; 10(8):617-28. PubMed ID: 10599541
[TBL] [Abstract][Full Text] [Related]
20. Insulin inhibits leukocyte-endothelium adherence via an Akt-NO-dependent mechanism in myocardial ischemia/reperfusion.
Li J; Wu F; Zhang H; Fu F; Ji L; Dong L; Li Q; Liu W; Zhang Y; Lv A; Wang H; Ren J; Gao F
J Mol Cell Cardiol; 2009 Oct; 47(4):512-9. PubMed ID: 19616003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
